Literature DB >> 25135686

Lipopolysaccharides belonging to different Salmonella serovars are differentially capable of activating Toll-like receptor 4.

Daniela Chessa1, Luisella Spiga2, Nicola De Riu3, Paola Delaconi2, Vittorio Mazzarello2, Giulia Ganau2, Salvatore Rubino4.   

Abstract

Salmonella enterica subsp. enterica serovar (serotype) Abortusovis is a member of the Enterobacteriaceae. This serotype is naturally restricted to ovine species and does not infect humans. Limited information is available about the immune response of sheep to S. Abortusovis. S. Abortusovis, like Salmonella enterica subsp. enterica serovar Typhi, causes a systemic infection in which, under natural conditions, animals are not able to raise a rapid immune response. Failure to induce the appropriate response allows pathogens to reach the placenta and results in an abortion. Lipopolysaccharides (LPSs) are pathogen-associated molecular patterns (PAMPs) that are specific to bacteria and are not synthesized by the host. Toll-like receptors (TLRs) are a family of receptors that specifically recognize PAMPs. As a first step, we were able to identify the presence of Toll-like receptor 4 (TLR4) on the ovine placenta by using an immunohistochemistry technique. To our knowledge, this is the first work describing the interaction between S. Abortusovis LPS and TLR4. Experiments using an embryonic cell line (HEK293) transfected with human and ovine TLR4s showed a reduction of interleukin 8 (IL-8) production by S. Abortusovis and Salmonella enterica subsp. enterica serovar Paratyphi upon LPS stimulation compared to Salmonella enterica subsp. enterica serovar Typhimurium. Identical results were observed using heat-killed bacteria instead of LPS. Based on data obtained with TLR4 in vitro stimulation, we demonstrated that the serotype S. Abortusovis is able to successfully evade the immune system whereas S. Typhimurium and other serovars fail to do so.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25135686      PMCID: PMC4249323          DOI: 10.1128/IAI.02297-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

Review 1.  Host adapted serotypes of Salmonella enterica.

Authors:  S Uzzau; D J Brown; T Wallis; S Rubino; G Leori; S Bernard; J Casadesús; D J Platt; J E Olsen
Journal:  Epidemiol Infect       Date:  2000-10       Impact factor: 2.451

Review 2.  The interface between innate and adaptive immunity.

Authors:  Kasper Hoebe; Edith Janssen; Bruce Beutler
Journal:  Nat Immunol       Date:  2004-10       Impact factor: 25.606

Review 3.  Capsule-mediated immune evasion: a new hypothesis explaining aspects of typhoid fever pathogenesis.

Authors:  Manuela Raffatellu; Daniela Chessa; R Paul Wilson; Cagla Tükel; Mustafa Akçelik; Andreas J Bäumler
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

4.  Abortion due to Salmonella enterica serovar Abortusovis (S. Abortusovis) in ewes is associated to a lack of production of IFN-gamma and can be prevented by immunization with inactivated S. Abortusovis vaccine.

Authors:  Monica Cagiola; Giulio Severi; Katia Forti; Miriam Menichelli; Paola Papa; Antonio De Giuseppe; Paolo Pasquali
Journal:  Vet Microbiol       Date:  2007-01-04       Impact factor: 3.293

Review 5.  From bench to bedside: stealth of enteroinvasive pathogens.

Authors:  Renée M Tsolis; Glenn M Young; Jay V Solnick; Andreas J Bäumler
Journal:  Nat Rev Microbiol       Date:  2008-10-28       Impact factor: 60.633

6.  Introduction: microbiology and immunology: lessons learned from Salmonella.

Authors:  S H Kaufmann; B Raupach; B B Finlay
Journal:  Microbes Infect       Date:  2001 Nov-Dec       Impact factor: 2.700

7.  Growth-phase regulation of lipopolysaccharide O-antigen chain length influences serum resistance in serovars of Salmonella.

Authors:  Denisse Bravo; Cecilia Silva; Javier A Carter; Anilei Hoare; Sergio A Álvarez; Carlos J Blondel; Mercedes Zaldívar; Miguel A Valvano; Inés Contreras
Journal:  J Med Microbiol       Date:  2008-08       Impact factor: 2.472

8.  Binding specificity of Salmonella plasmid-encoded fimbriae assessed by glycomics.

Authors:  Daniela Chessa; Caleb W Dorsey; Maria Winter; Andreas J Baümler
Journal:  J Biol Chem       Date:  2008-01-22       Impact factor: 5.157

9.  The Vi-capsule prevents Toll-like receptor 4 recognition of Salmonella.

Authors:  R Paul Wilson; Manuela Raffatellu; Daniela Chessa; Sebastian E Winter; Cagla Tükel; Andreas J Bäumler
Journal:  Cell Microbiol       Date:  2007-11-22       Impact factor: 3.715

10.  Contribution of fimbrial operons to attachment to and invasion of epithelial cell lines by Salmonella typhimurium.

Authors:  A J Bäumler; R M Tsolis; F Heffron
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

View more
  4 in total

1.  Specific inhibition of c-Jun N-terminal kinase delays preterm labour and reduces mortality.

Authors:  Grisha Pirianov; David A MacIntyre; Yun Lee; Simon N Waddington; Vasso Terzidou; Huseyin Mehmet; Phillip R Bennett
Journal:  Reproduction       Date:  2015-07-16       Impact factor: 3.906

Review 2.  Campylobacteriosis, Salmonellosis, Yersiniosis, and Listeriosis as Zoonotic Foodborne Diseases: A Review.

Authors:  Agnieszka Chlebicz; Katarzyna Śliżewska
Journal:  Int J Environ Res Public Health       Date:  2018-04-26       Impact factor: 3.390

3.  A general strategy to control antibody specificity against targets showing molecular and biological similarity: Salmonella case study.

Authors:  Riccardo Marega; N Desroche; A-C Huet; M Paulus; C Suarez Pantaleon; D Larose; P Arbault; P Delahaut; N Gillard
Journal:  Sci Rep       Date:  2020-10-28       Impact factor: 4.379

Review 4.  Host restriction, pathogenesis and chronic carriage of typhoidal Salmonella.

Authors:  Amber J Barton; Jennifer Hill; Christoph J Blohmke; Andrew J Pollard
Journal:  FEMS Microbiol Rev       Date:  2021-09-08       Impact factor: 16.408

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.